Search results
Results from the WOW.Com Content Network
DaVita's (DVA) latest study indicates favorable outcomes for ESKD patients regarding the COVID-19 vaccines.
Kidney dialysis patients are among those most at risk from COVID-19, which is especially deadly among people with chronic illnesses. Dialysis clinics provide new path for delivery of stockpiled ...
Marty Verel, a 59-year-old kidney transplant recipient in Ohio, should have been near the top of the list to receive a COVID-19 vaccine. Yet like millions of others, he wasn’t having any luck ...
The Janssen COVID‑19 vaccine, (Ad26.COV2.S) sold under the brand name Jcovden, [1] is a COVID‑19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands, [24] and its Belgian parent company Janssen Pharmaceuticals, [25] a subsidiary of American company Johnson & Johnson.
The reasoning is because in the 20-29 age range the benefits to individual of vaccination were less as their likelihood of harm from COVID‑19 is less and closer to the potential risk of harm from the vaccine (at a medium exposure risk with COVID‑19 infection cases running at a rate of 60 per 100,000).
Minhai COVID-19 vaccine (Chinese: 康泰民海新冠疫苗), trademarked as KCONVAC (Chinese: 可维克; pinyin: Kěwéikè), is a COVID-19 vaccine developed by Shenzhen Kangtai Biological Products Co. Ltd and its subsidiary, Beijing Minhai Biotechnology Co., Ltd.
The Centers for Disease Control and Prevention has said it is monitoring reports of myocarditis, an inflammation of the heart muscle, and pericarditis, an inflammation of the outer lining of the ...
The updated COVID-19 vaccine is now available. Infectious disease doctors recommend being smart about the timing of your shot. You can expect similar side effects to the previous vaccines if you ...